Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS

NCT00465296 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

200

Enrollment

OTHER

Sponsor class

Stopped Funding Discontinued

Conditions

Metabolic Syndrome

Interventions

DRUG: rosiglitazone

Sponsor

Medstar Health Research Institute

Collaborators

[object Object]